DRI Healthcare Trust is dedicated to the strategic expansion and oversight of an investment collection focused on pharmaceutical royalty income. The company currently possesses 18 distinct royalty streams, which originate from the sales of 14 varied pharmaceutical products across eight separate medical treatment categories. Established in 2020, its primary corporate offices are situated in Toronto, Canada.